I like:
- Increase of 121% on the March quarter 2019.
- Financial year-end Cash Receipts to June 2019 of $32,221,000 wereup 36% compared to the prior financial year (to June 2018).- This indicates that more EPP patients in Europe arereceiving treatment with SCENESSE® and we look forward to the time the same treatment access can be provided toAmerican EPP patients who have no current alternatives.”
- Net Cash from Operations was positive by $8,618,000 in the June quarter 2019. Net Cash from Operations for thetwelve months to 30 June 2019 was a positive $18,382,000 compared to a positive $11,693,000 in the same twelvemonth period to 30 June 2018.
- Increasing cash balance - Cash Balance as at 30 June2019 increased to $54,269,000, compared to $44,975,000 as at 31 March 2019 and $36,198,000 as at 30 June 2018.
Very positive outlook and building blocks foundation.
Well done!
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.28%
!
$9.99

I like:- Increase of 121% on the March quarter 2019.- Financial...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.99 |
Change
-0.130(1.28%) |
Mkt cap ! $499.7M |
Open | High | Low | Value | Volume |
$10.08 | $10.30 | $9.93 | $695.9K | 69.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9911 | $9.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.01 | 344 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9911 | 9.950 |
1 | 500 | 9.900 |
1 | 425 | 9.890 |
1 | 5000 | 9.850 |
2 | 4500 | 9.750 |
Price($) | Vol. | No. |
---|---|---|
10.010 | 344 | 1 |
10.040 | 1666 | 1 |
10.180 | 1000 | 1 |
10.200 | 500 | 1 |
10.220 | 2004 | 1 |
Last trade - 16.10pm 02/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online